康臣药业(01681)12月11日斥资211.18万港元回购14.1万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Company Actions - 康臣药业 plans to repurchase 141,000 shares at a total cost of HKD 2.1118 million [1] - The buyback price is set between HKD 14.9 and HKD 15.0 per share [1]